Kobayashi Pharmaceutical Scandal Threatens 33,000 Japanese Enterprises
An investigation reveals that Kobayashi Pharmaceutical’s red yeast rice products may impact up to 33,000 enterprises in Japan, following health concerns and product recalls.
News & Insights Across Asia
An investigation reveals that Kobayashi Pharmaceutical’s red yeast rice products may impact up to 33,000 enterprises in Japan, following health concerns and product recalls.
Japanese health authorities are investigating Kobayashi Pharmaceutical’s factory amid deaths linked to their red yeast rice supplement. The probe seeks to uncover the cause behind the health issues.
An unintended substance found in Kobayashi Pharmaceutical’s supplements in Japan has been linked to multiple deaths and hospitalizations, prompting an investigation into the contamination.
Five deaths have been linked to red yeast rice supplements produced by Japan’s Kobayashi Pharmaceutical, sparking a crisis of confidence. Experts urge immediate action as recalls spread and inquiries surge.
Two more deaths have been linked to Kobayashi Pharma’s “beni-koji choleste help” supplement in Japan, raising concerns over the safety of dietary supplements and prompting government action.